Epirubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Dosage, Application, and Distribution Channel

List of Tables

The global epirubicin market is expected to reach 243.99 million by 2028 from US$ 191.66 million in 2021. The market is estimated to grow at a CAGR of 3.60% from 2022 to 2028.

Epirubicin hydrochloride is a class of drugs termed anthracyclines and is primarily used to treat breast cancers after surgical resection. Anthracyclines are antibiotics isolated from the gram-positive bacteria Streptomyces. They are commonly used as chemotherapy agents and exert their antineoplastic effects by targeting the replication of DNA. Epirubicin HCl is often preferred over anthracycline doxorubicin as it has been shown to have fewer side effects. Epirubicin HCl became FDA-approved (Food and Drug Administration) as adjuvant therapy for treating axillary node-positive breast cancers following resection under the trade name Ellence in 1999.

The growing pharmaceutical industry worldwide is also likely to create growth opportunities for the epirubicin market. The US pharmaceutical market is the largest and the most commercial market in North America. The US alone holds over 45% of the global pharmaceutical market. The majority of the top global drug manufacturing companies are from the US, and the nation has been at the forefront of biomedical research.

Further, the pharmaceutical market in Germany holds the fourth position in the global pharmaceutical market with small and mid-sized companies. According to the International Trade Administration (ITA), in 2019, the pharmaceutical market in Germany accounted for US$ 62.5 billion. The country is likely to remain one of the most attractive destinations for the global pharmaceutical industry in the coming years in terms of manufacturing and supply. The market is driven by factors such as increasing investment in research and development and growing patent applications.

Also, the pharmaceutical industry in the UK is continuously expanding. Under the UK's pharmaceutical industry, over 610 companies are operating. According to Office National Statistics, 610 companies were operating in the UK in 2018. It has over 15 global companies headquartered in the UK. Also, nearly 41% of pharmaceutical production is exported to other countries and regions. Companies such as Astra Zeneca, Eli Lilly, and GSK have contributed significantly to the growth of pharmaceuticals and led research and development at a peak. The growth of these companies and expansions in the business segments are expected to influence market growth in the coming years.

In August 2020, the Government of India announced a program called Atmanirbhar Bharat, which means self-reliant India, as financial support to grow the pharmaceutical industry. Like the US and Europe, India has adopted independent manufacturing of pharmaceutical raw materials. Additionally, US$ 1.8 billion have been allocated for Production Linked Incentive Scheme (PLI) program for pharmaceuticals. This has provided an opportunity for India to become a global hub for the pharmaceutical & medical device industry. Nearly 30% of the investments are offered to the pharmaceutical industry to produce raw materials and intermediates essential to make antibiotics, analgesics, and other active pharmaceutical ingredients (API) .

Thus, the growing pharmaceutical sector worldwide is likely to create growth opportunities for the epirubicin market.

Based on dosage, the global epirubicin market is segmented into 10mg/vial, 50mg/vial, 100mg/vial, and 200mg/vial. The 50mg/vial segment held the largest share of the market in 2021; however, the 100mg/vial segment is anticipated to register the highest CAGR during the forecast period. In terms of application, the global epirubicin market is segmented into breast cancer, liver cancer, bladder cancer, and others. The breast cancer segment held the largest share of the market in 2021. The same segment is anticipated to register the highest CAGR during the forecast period. The increasing prevalence of breast cancer in the US is likely to increase the demand for epirubicin. According to the Centers for Disease Control and Prevention (CDC), every year in the US, ~2,64,000 breast cancer cases are diagnosed in women and ~2,400 in men. It is also estimated that ~42,000 women and ~500 men in the US die each year from breast cancer. Based on distribution channel, the global epirubicin market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2021, and the same segment is anticipated to register the highest CAGR during the forecast period.

A few key primary and secondary sources referred to while preparing the report on the epirubicin market are the World Health Organization (WHO), Cancer Intervention and Surveillance Modeling Network Breast Cancer Surveillance Consortium, American Society of Clinical Oncology, and Centers for Disease Control and Prevention.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the epirubicin market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global epirubicin market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00008627

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Epirubicin Market - By Dosage
- 1.3.2 Global Epirubicin Market - By Application
- 1.3.3 Global Epirubicin Market - By Distribution Channel
- 1.3.4 Global Epirubicin Market - By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Epirubicin Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East And Africa PEST Analysis
- 4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion

5. Epirubicin Market- Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Cancer
- 5.1.2 Increasing Awareness Regarding Cancer
5.2 Market Restraints
- 5.2.1 Elevated Risk of Adverse Effects due to Epirubicin
5.3 Market Opportunities
- 5.3.1 Rising FDA Approvals for Cancer Drugs
5.4 Future Trends
- 5.4.1 Increase in Number of Cancer Research Programs
5.5 Impact Analysis

6. Epirubicin Market- Global Analysis

6.1 Global Epirubicin Market Revenue Forecasts and Analysis
6.2 Global Epirubicin Market, By Geography - Forecasts And Analysis
6.3 Global Epirubicin Market - Market Potential Analysis, By Region
6.4 Company Analysis
- 6.4.1 Market Positioning of Key Players
- 6.4.2 Comparative Company Analysis
6.5 Performance of Key Players
- 6.5.1 Pfizer, Inc.
- 6.5.2 Teva Pharmaceutical Industries Ltd.

7. Epirubicin Market Analysis - By Dosage

7.1 Overview
7.2 Global Epirubicin Market, by Dosage, 2022 & 2028 (%)
7.3mg/Vial
- 7.3.1 Overview
- 7.3.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
7.4mg/Vial
- 7.4.1 Overview
- 7.4.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
7.5mg/Vial
- 7.5.1 Overview
- 7.5.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)
7.6mg/Vial
- 7.6.1 Overview
- 7.6.2 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

8. Epirubicin Market Analysis and Forecast to 2028 - Application

8.1 Overview
8.2 Global Epirubicin Market, by Application, 2022 & 2028 (%)
8.3 Breast Cancer
- 8.3.1 Overview
- 8.3.2 Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
8.4 Liver Cancer
- 8.4.1 Overview
- 8.4.2 Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
8.5 Bladder Cancer
- 8.5.1 Overview
- 8.5.2 Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Other Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

9. Epirubicin Market Analysis and Forecast to 2028 - Distribution Channel

9.1 Overview
9.2 Global Epirubicin Market, by Distribution Channel, 2022 & 2028 (%)
9.3 Hospital Pharmacies
- 9.3.1 Overview
- 9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
9.4 Retail Pharmacies
- 9.4.1 Overview
- 9.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)
9.5 Online Pharmacies
- 9.5.1 Overview
- 9.5.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

10. Global Epirubicin Market - Geographic Analysis

10.1 North America: Epirubicin Market
- 10.1.1 Overview
- 10.1.2 North America: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
- 10.1.3 North America: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
- 10.1.4 North America: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
- 10.1.5 North America: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
- 10.1.6 North America: Epirubicin Market, by Country, 2022 & 2028 (%)
  - 10.1.6.1 US: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.1.6.1.1 Overview
    - 10.1.6.1.2 US: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.1.6.1.3 US: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.1.6.1.4 US: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.1.6.1.5 US: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.1.6.2 Canada: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.1.6.2.1 Overview
    - 10.1.6.2.2 Canada: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.1.6.2.3 Canada: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.1.6.2.4 Canada: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.1.6.2.5 Canada: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.1.6.3 Mexico: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.1.6.3.1 Overview
    - 10.1.6.3.2 Mexico: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.1.6.3.3 Mexico: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.1.6.3.4 Mexico: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.1.6.3.5 Mexico: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
10.2 Europe: Epirubicin Market
- 10.2.1 Overview
- 10.2.2 Europe: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
- 10.2.3 Europe: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
- 10.2.4 Europe: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
- 10.2.5 Europe: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
- 10.2.6 Europe: Epirubicin Market, by Country, 2022 & 2028 (%)
  - 10.2.6.1 Germany: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.1.1 Overview
    - 10.2.6.1.2 Germany: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.1.3 Germany: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.2.6.1.4 Germany: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.2.6.1.5 Germany: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.2.6.2 UK: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.2.1 Overview
    - 10.2.6.2.2 UK: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.2.3 UK: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.2.6.2.4 UK: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.2.6.2.5 UK: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.2.6.3 France: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.3.1 Overview
    - 10.2.6.3.2 France: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.3.3 France: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.2.6.3.4 France: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.2.6.3.5 France: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.2.6.4 Italy: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.4.1 Overview
    - 10.2.6.4.2 Italy: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.4.3 Italy: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.2.6.4.4 Italy: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.2.6.4.5 Italy: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.2.6.5 Spain: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.5.1 Overview
    - 10.2.6.5.2 Spain: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.5.3 Spain: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.2.6.5.4 Spain: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.2.6.5.5 Spain: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.2.6.6 Rest of Europe: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.6.1 Overview
    - 10.2.6.6.2 Rest of Europe: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.2.6.6.3 Rest of Europe: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.2.6.6.4 Rest of Europe: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.2.6.6.5 Rest of Europe: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
10.3 Asia Pacific: Epirubicin Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
- 10.3.3 Asia Pacific: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
- 10.3.4 Asia Pacific: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
- 10.3.5 Asia Pacific: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
- 10.3.6 Asia Pacific: Epirubicin Market, by Country, 2022 & 2028 (%)
  - 10.3.6.1 China Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
    - 10.3.6.1.1 Overview
    - 10.3.6.1.2 China: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.3.6.1.3 China: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.3.6.1.4 China: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.3.6.1.5 China: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.3.6.2 Japan Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
    - 10.3.6.2.1 Overview
    - 10.3.6.2.2 Japan: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.3.6.2.3 Japan: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.3.6.2.4 Japan: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.3.6.2.5 Japan: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.3.6.3 India Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
    - 10.3.6.3.1 Overview
    - 10.3.6.3.2 India: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.3.6.3.3 India: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.3.6.3.4 India: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.3.6.3.5 India: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.3.6.4 South Korea Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
    - 10.3.6.4.1 Overview
    - 10.3.6.4.2 South Korea: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.3.6.4.3 South Korea: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.3.6.4.4 South Korea: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.3.6.4.5 South Korea: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.3.6.5 Australia Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
    - 10.3.6.5.1 Overview
    - 10.3.6.5.2 Australia: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.3.6.5.3 Australia: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.3.6.5.4 Australia: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.3.6.5.5 Australia: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
  - 10.3.6.6 Rest of Asia Pacific Epirubicin Market Revenue and Forecasts to 2028 (US$ Thousand)
    - 10.3.6.6.1 Overview
    - 10.3.6.6.2 Rest of Asia Pacific: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 10.3.6.6.3 Rest of Asia Pacific: Epirubicin Market, by Dosage, 2019-2028 (US$ Thousand)
    - 10.3.6.6.4 Rest of Asia Pacific: Epirubicin Market, by Application, 2019-2028 (US$ Thousand)
    - 10.3.6.6.5 Rest of Asia Pacific: Epirubicin Market, by Distribution Channel, 2019-2028 (US$ Thousand)
10.4 Middle East & Africa Epirubicin Market Revenue and Forecasts To 2028
- 10.4.1 Overview
- 10.4.2 Middle East & Africa: Epirubicin Market - Revenue and Forecast to 2028 (US$ Thousand)
- 10.4.3 Middle East & Africa: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
- 10.4.4 Middle East & Africa Epirubicin Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
- 10.4.5 Middle East & Africa Epirubicin Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Thousand)
- 10.4.6 Middle East & Africa: Epirubicin Market, by Country, 2022 & 2028 (%)
  - 10.4.6.1 Saudi Arabia: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.1.1 Saudi Arabia: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.1.2 Saudi Arabia: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
    - 10.4.6.1.3 Saudi Arabia Epirubicin Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.1.4 Saudi Arabia Epirubicin Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Thousand)
  - 10.4.6.2 UAE: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.2.1 UAE: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.2.2 UAE: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
    - 10.4.6.2.3 UAE Epirubicin Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.2.4 UAE Epirubicin Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Thousand)
  - 10.4.6.3 South Africa: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.3.1 South Africa: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.3.2 South Africa: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
    - 10.4.6.3.3 South Africa Epirubicin Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.3.4 South Africa Epirubicin Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Thousand)
  - 10.4.6.4 Rest of Middle East & Africa: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.4.1 Rest of Middle East & Africa: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.4.6.4.2 Rest of Middle East & Africa: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
    - 10.4.6.4.3 Rest of Middle East & Africa: Epirubicin Market, by Application, 2019-2028 (USD Thousand)
    - 10.4.6.4.4 Rest of Middle East & Africa: Epirubicin Market, by Distribution Channel, 2019-2028 (USD Thousand)
10.5 South and Central America Epirubicin Market Revenue and Forecasts To 2028
- 10.5.1 Overview
- 10.5.2 South and Central America: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
- 10.5.3 South and Central America: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
- 10.5.4 South and Central America: Epirubicin Market, by Application, 2019-2028 (USD Thousand)
- 10.5.5 South and Central America: Epirubicin Market, by Distribution Channel, 2019-2028 (USD Thousand)
- 10.5.6 South and Central America: Epirubicin Market, by Country, 2022 & 2028 (%)
  - 10.5.6.1 Brazil: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.5.6.1.1 Overview
    - 10.5.6.1.2 Brazil: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.5.6.1.3 Brazil: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
    - 10.5.6.1.4 Brazil: Epirubicin Market, by Application, 2019-2028 (USD Thousand)
    - 10.5.6.1.5 Brazil: Epirubicin Market, by Distribution Channel, 2019-2028 (USD Thousand)
  - 10.5.6.2 Argentina: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.5.6.2.1 Overview
    - 10.5.6.2.2 Argentina: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.5.6.2.3 Argentina: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
    - 10.5.6.2.4 Argentina: Epirubicin Market, by Application, 2019-2028 (USD Thousand)
    - 10.5.6.2.5 Argentina: Epirubicin Market, by Distribution Channel, 2019-2028 (USD Thousand)
  - 10.5.6.3 Rest of South and Central America: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.5.6.3.1 Overview
    - 10.5.6.3.2 Rest of South and Central America: Epirubicin Market - Revenue and Forecast to 2028 (USD Thousand)
    - 10.5.6.3.3 Rest of South and Central America: Epirubicin Market, by Dosage, 2019-2028 (USD Thousand)
    - 10.5.6.3.4 Rest of South and Central America: Epirubicin Market, by Application, 2019-2028 (USD Thousand)
    - 10.5.6.3.5 Rest of South and Central America: Epirubicin Market, by Distribution Channel, 2019-2028 (USD Thousand)

11. Impact of COVID-19 Pandemic on Global Epirubicin Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Epirubicin Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies
- 12.2.1 Overview

13. Company Profiles

13.1 Pfizer Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Salius Pharma Pvt Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Areva Pharmaceuticals
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 MYLAN N.V.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Hikma Pharmaceuticals PLC
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Fresenius Kabi AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 MIRACALUS PHARMA PVT. LTD.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms